Expand ASMB Menu
ASMB MENU

ASMB Latest Press Releases

-- December 8, 2025 --

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes Globe Newswire 4:05 PM

-- November 10, 2025 --

Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates Globe Newswire 4:05 PM

-- November 7, 2025 --

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting Globe Newswire 8:00 AM

-- October 14, 2025 --

Assembly Biosciences Announces Upcoming Investor Conference Participation Globe Newswire 7:00 AM

-- October 10, 2025 --

Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe Globe Newswire 8:00 AM

-- August 8, 2025 --

Assembly Biosciences Announces Pricing of $175 Million in Equity Financings Globe Newswire 8:05 AM
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes Globe Newswire 8:00 AM

-- August 6, 2025 --

Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus Globe Newswire 4:05 PM
Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates Globe Newswire 4:05 PM

-- July 26, 2025 --

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop Globe Newswire 3:00 AM
Market Data Delayed 15 Minutes